Is it okay to have a Transvaginal Scan (TVS) while menstruating?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Transvaginal Scan During Menstruation

Yes, it is absolutely safe and appropriate to perform a transvaginal scan (TVS) while menstruating—menstruation is not a contraindication to transvaginal ultrasound. 1

Primary Recommendation

  • The American College of Emergency Physicians explicitly states that transvaginal ultrasound can be performed safely during any phase of the menstrual cycle, including active menstruation. 1

  • Transvaginal ultrasound remains the first-line imaging approach for evaluating pelvic structures in reproductive-aged women regardless of menstrual status, due to its superior resolution and diagnostic accuracy compared to other modalities. 1

  • The American College of Radiology guidelines for obstetrical and gynecological imaging do not list menstruation as a contraindication or limitation for transvaginal scanning. 2, 3

Technical Considerations During Menstruation

  • While TVS can be performed during menstruation, the presence of menstrual blood may slightly affect visualization quality in some cases, but this does not preclude the examination. 4

  • The endometrial thickness interpretation varies with menstrual cycle phase in premenopausal women, so the radiologist should be informed of the patient's menstrual status for appropriate interpretation. 4

  • For specific procedures like hysterosalpingo-contrast sonography (HyCoSy), timing after menstruation matters more for technical reasons—performing the study 7-10 days after menstruation or when endometrial thickness exceeds 5.45 mm reduces complications like venous intravasation. 5 However, this is specific to contrast studies, not routine diagnostic TVS.

Important Distinction: TVS vs. Pap Testing

  • Do not confuse transvaginal ultrasound with Pap testing—these are different procedures with different requirements. 6

  • Conventional cytology Pap testing should be postponed if the patient is menstruating and rescheduled at the earliest opportunity, as menstrual blood can interfere with cytological interpretation. 6

  • However, this Pap testing restriction does not apply to transvaginal ultrasound, which uses sound waves rather than cellular sampling. 1

Common Clinical Pitfalls to Avoid

  • Never default to transrectal ultrasound simply because the patient is menstruating—this is an inappropriate substitution as menstruation is not a contraindication to TVS. 1

  • Transrectal ultrasound should only be used when transvaginal ultrasound is either declined by the patient or deemed not feasible for other reasons (such as vaginal stenosis or patient preference). 2, 1

  • Transabdominal ultrasound alone provides insufficient resolution for comprehensive pelvic evaluation and should not be used as a substitute when TVS is indicated, regardless of menstrual status. 1

Patient Counseling

  • Proper patient counseling should include explaining that menstruation does not prevent the examination and that the procedure can proceed safely. 1

  • The presence of a chaperone is essential throughout the transvaginal examination procedure, as recommended for all TVS examinations. 1

  • The patient should empty her bladder before transvaginal scanning to optimize image quality and comfort, which is standard practice regardless of menstrual status. 1

References

Guideline

Transvaginal Ultrasound Guidelines for Reproductive-Aged Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

acr appropriateness criteria® second and third trimester vaginal bleeding.

Journal of the American College of Radiology, 2020

Guideline

acr appropriateness criteria® assessment of gravid cervix.

Journal of the American College of Radiology, 2020

Guideline

acr appropriateness criteria® abnormal uterine bleeding.

Journal of the American College of Radiology, 2020

Guideline

Gynecological Examination Guidelines for Reproductive-Age Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What type of ultrasound should be ordered for a female patient of reproductive age with persistent vaginal bleeding 1 week after a miscarriage?
What is the cutoff for endometrial thickness on Transvaginal Ultrasound (TVUS) for postmenopausal bleeding?
In a postmenopausal woman with vaginal bleeding and a 6 mm endometrial thickness on transvaginal ultrasound, what is the appropriate next step in management?
What are the ACOG 2026 guidelines for evaluating and managing postmenopausal bleeding?
In a 41-year-old woman seeking contraception with no abnormal uterine bleeding or menstrual irregularities, what is the most appropriate investigation before initiating contraception?
What is the most appropriate next step in management for a child with chronic constipation, soiling, abdominal discomfort, and a palpable mass in the lower abdomen consistent with stool impaction?
Does a runny nose in a 10-month-old infant with persistent fever establish a diagnosis of upper respiratory tract infection (URTI) and remove the need for further invasive investigations?
What vaccinations are recommended for an asplenic (without a spleen) adult in India, particularly if pregnant or postpartum, according to the Indian adult vaccination schedule?
What is the risk of tuberculosis (TB) infection in patients taking denosumab (Prolia), particularly those with risk factors for TB, such as a history of TB exposure or residence in a region with high TB prevalence?
What is the recommended treatment for a patient with acute hepatitis B infection?
What is the role of intramuscular (IM) epinephrine in managing a patient with a chronic obstructive pulmonary disease (COPD) exacerbation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.